According to a new market research report, the Allergy Treatment industry is expected to grow from $24.65 billion in 2017 to $40.36 billion by 2025, registering a CAGR of 6.3% from 2018 to 2025. The report, published by Allied Market Research, is titled “Allergy Treatment Market by Type, Treatment, and End User: Global Opportunity Analysis and Industry Forecast, 2018-2025.” The report presents comprehensive analyses of the global market by examining market dynamics, top investment pockets, key player positioning, and the overall competitive landscape.
Understanding the Allergy Treatment Market
Allergies have become one of the most significant public health concerns across the globe. An allergy is essentially a hypersensitive reaction triggered by the immune system in response to foreign substances known as allergens. These allergens can range from common environmental elements like pollens, dust mites, molds, and pet dander to certain foods and other substances that the immune system identifies as threats. Patients who are prone to developing such reactions are medically referred to as allergic or atopic individuals.
Access Sample Data & Findings:
https://www.alliedmarketresearch.com/request-sample/3541
Key Drivers Shaping Market Growth
The rising prevalence of allergic conditions across both developed and developing economies has created a strong and consistent demand for effective allergy treatment solutions. Among all types of allergies, rhinitis and asthma remain the most commonly diagnosed conditions worldwide. However, incidents of food allergies have also witnessed a notable rise in recent years, adding further momentum to the overall growth of the allergy treatment market.
The global allergy treatment market is being driven by a combination of clinical, environmental, and socioeconomic factors. The increased prevalence of allergens in everyday environments and the high consumption of tobacco, which is known to induce and aggravate several allergic conditions, are among the primary drivers of market expansion. Additionally, the growing focus on the development of allergy-specific drugs and the advent of immunotherapy as a long-term treatment solution have opened new avenues for pharmaceutical companies and healthcare providers alike.
Segment Analysis: Breaking Down the Market
By type, the rhinitis segment generated the highest revenue in 2017 and is expected to maintain its dominance throughout the forecast period. This is primarily attributed to the widespread prevalence of allergic rhinitis on a global scale. According to the European Academy of Allergy and Clinical Immunology (EAACI), approximately 400 million patients around the world suffer from rhinitis, making it one of the most commonly reported allergic conditions globally. Despite this dominance, the food allergy segment is projected to register the highest growth rate during the forecast period, reflecting the growing incidence of food-related allergic reactions across diverse age groups and geographies.
By treatment, the market is segmented into anti-allergy medicine and immunotherapy. The immunotherapy segment stands out as the fastest-growing category, expected to register a CAGR of 8.5% from 2018 to 2025. Immunotherapy works by gradually desensitizing the immune system to specific allergens, offering a more permanent and targeted solution compared to traditional antihistamines and medications. As awareness and acceptance of immunotherapy continue to grow among both patients and healthcare professionals, the segment is poised for robust expansion in the years ahead.
Regional Outlook: North America Leads, Asia-Pacific Grows Fastest
From a regional perspective, North America contributed approximately one-third of the total market revenue in 2017 and is estimated to maintain its leadership position throughout the forecast period. The region benefits from a well-established healthcare infrastructure, a high rate of diagnosis and treatment of allergic conditions, and strong adoption of immunotherapy solutions. The United States, in particular, generated the highest revenue in the global allergy treatment market in 2017, accounting for more than half of the market share within North America.
Asia-Pacific is anticipated to experience the fastest growth, registering a CAGR of 7.5% through 2025, driven by rising prevalence of allergic diseases such as asthma and rhinitis, improving healthcare infrastructure, increasing disposable incomes, and growing patient awareness across the region. Europe and Latin America, Middle East, and Africa (LAMEA) are also analyzed in the report, with both regions expected to contribute meaningfully to the overall market growth during the forecast period.
★ See What’s Inside This Report @
https://www.alliedmarketresearch.com/purchase-enquiry/3541
Competitive Landscape and Key Market Players
Rising awareness among patients regarding food allergies and their long-term health implications is also expected to create lucrative opportunities for market players in the coming years. As more individuals become informed about the nature of allergic reactions and the treatment options available, the demand for both medicinal and immunotherapy-based solutions is expected to increase substantially. Patent expiries and increasing competition from generic drugs, however, continue to challenge the revenue margins of leading pharmaceutical companies operating in this space.
The global allergy treatment market features leading players including GlaxoSmithKline, Allergopharma, Allergan Inc., Schering-Plough Corporation, Collegium Pharmaceutical Inc., Allergy Therapeutics, Allergon, Genentech Inc., McNeil Consumer Healthcare, and Meda Pharmaceuticals Inc. These companies have adopted a range of strategies to sustain and grow their market presence, including partnerships, collaborations, mergers and acquisitions, and new product launches. The competitive landscape remains dynamic, with ongoing investments in research and development aimed at introducing more effective and targeted allergy treatment solutions to meet the growing global demand through 2025 and beyond.
About Us
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides end-to-end solutions along with information, education, advocacy, and networking resources to SMEs and early-stage start-ups to bring excellence to their processes. In addition, we offer a nurturing environment required to develop and grow businesses, including business planning; virtual support; market intelligence; acquiring resources; and getting direct access to finance, suppliers, and other experts to boost the growth of businesses and entrepreneurs.
Our bundled and hassle-free business support systems are customized to meet the needs of SME consultants and industry leaders. Moreover, our large network of skilled consultants and experts help start-ups get the business on a roll.
Contact:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]




